Razoxane
-
Razoxane
structure -
-
CAS No:
21416-67-1
-
Formula:
C11H16N4O4
-
Chemical Name:
Razoxane
-
Synonyms:
2,6-Piperazinedione,4,4′-(1-methyl-1,2-ethanediyl)bis-;2,6-Piperazinedione,4,4′-propylenedi-;4,4′-(1-Methyl-1,2-ethanediyl)bis[2,6-piperazinedione];1,2-Bis(3,5-dioxo-1-piperazinyl)propane;4,4′-Propylenedi(2,6-piperazinedione);4,4′-Propylenebis(2,6-piperazinedione);ICRF 159;ICI 59118;Razoxin;Troxozone;(±)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane;(±)-1,2-Bis(3,5-dioxopiperazinyl)propane;Tepirone;NSC 129943;Razoxane;21416-87-5;35259-82-6;78673-26-4;83713-23-9
- Categories:
-
CAS No:
Description
Razoxane is a N-alkylpiperazine.|An antimitotic agent with immunosuppressive properties.
Characteristics
98.8
-1.4
1.333g/cm3
237-239 °C
583.5°C at 760 mmHg
275.3ºC
1.534
DMSO: soluble40mg/mL
room temp
Drug Information
Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS. (See all compounds classified as Antimitotic Agents.)
ICRF 159
Razoxane Use and Manufacturing
The racemic form of ADR- 925 (ICRF-198) (MW = 304 g/mol) was prepared in house according to the procedure described previously (Kovarikova et al., 2011). Briefly, At the beginning of each working day the capillary was flushed with NaOH 0.1M for 10min, 5min with Milli-Q water and 40min with the buffer in basic conditions and with MeOH for 5min, NaOH 1M for 25min, 5 min with Milli-Q water, 5min with HCl 0.1M and 30min with the buffer in acid conditions. In order to ensure the repeatability between injections, the capillary was flushed with NaOH 0.1M for 5min, 5min with the buffer and 2min with the BGE in basic or acid conditions. Buffer solutions were prepared by dissolving the appropriate amount of formic acid, acetic acid, ammonium bicarbonate or boric acid in Milli-Q water, adjusting the pH to the desired value (pH 2.5, 5.0, 7.0, or 9.0, respectively) with 0.1 or 1M NaOH before completing the volume with water to get the desired buffer concentration. Finally, BGEs were prepared by dissolving the appropriate amount of the chiral selectors in the buffer solution. Stock standard solutions of racemic captopril, econazole and clenbuterol were prepared by dissolving the appropriate amount of these drugs in MeOH and EXAMPLE 8 dl-1, 2-bis(3, 5-Dioxopiperazin-1-yl)propane N, N, N', N'-Tetracarboxamidomethyl-1, 2-diaminopropane (0.5 g.), prepared essentially by the method of Badinard et al. (loc. cit.), and phenol (10 g.) are heated together under nitrogen at 165C for 20 hours. The phenol is removed by evaporation under reduced pressure and the residue triturated with methanol, cooled in ice and filtered to give dl-1, 2-bis(3, 5-dioxopiperazin-1-yl) propane (0.44 g., 82%) m.p. 235-236C.dl-1, 2-bis(3, 5-Dioxopiperazin-1-yl)propane 1, 2-Diaminopropane tetra-acetic acid (100 g.) and formamide (400 ml.) are heated together at reduced pressure under nitrogen at 100-110C for 1 hour, and then at 150-155C for 4 hours. The brown solution is evaporated under reduced pressure at 80-90C and the residue taken up in methanol (120 ml.) and cooled in the refrigerator overnight. Filtration, followed by washing with cold methanol and vacuum drying at 65C gives dl-EXAMPLE 3 d-1, 2-bis(3, 5-Dioxopiperazin-1-yl)propane d-1, 2-Diaminopropane tetra-acetic acid monohydrate, [alpha]D + 47.1 (c. 0.5% in water), prepared essentially by the method of Dwyer and Garvan, J. Amer. Chem. Soc., 1959, 81, 2956, is reacted with formamide by the method described in to give a 43% yield of d-EXAMPLE 4 l-1, 2-bis(3, 5-Dioxopiperazin-1-yl)propane l, 1, 2-Diaminopropane tetra-acetic acid monohydrate, [alpha]D - 44.2 (c. 0.5% in water), prepared essentially by the method of Dwyer and Garvan (loc. cit.), is reacted with formamide by the method described in to give a 36% yield of l-EXAMPLE 8 dl-1, 2-Bis[4-(N-methylpiperazinomethyl)-3, 5-dioxopiperazin-1-yl]-propane A mixture of N-methylpiperazine (2.21 ml, 20.0 m mole), DMF (25 ml), chloroform (6 ml) and EXAMPLE 6 dl-1, 2-Bis[4-(3, 5-dimethylpiperidinomethyl)-3, 5-dioxopiperazin-1-yl]-propan A mixture of 3, 5-dimethylpiperidine (2.8 ml, 21 m mole), DMF (15 ml), 1, 4-dioxane (15 ml) and dl-1, 2-Bis(4-morpholinomethyl-3, 5-dioxopiperazin-1-yl)-propane A mixture of EXAMPLE 7 dl-1, 2-Bis[4-(N-phenylpiperazinomethyl)-3, 5-dioxopiperazin-1-yl]-propane A mixture of N-phenylpiperazine (2.9 g, 17.7 m mole), DMF (20 ml), absolute ethanol (5 ml) and
Computed Properties
Molecular Weight:268.27
XLogP3:-1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:3
Exact Mass:268.11715500
Monoisotopic Mass:268.11715500
Topological Polar Surface Area:98.8
Heavy Atom Count:19
Complexity:404
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Razoxane
-
CN
3 YRS
Business licensedDistributor Supplier of Reference Listed Drugs,Excipients,Intermediates,Impurity Standards,API
Latest News on Razoxane
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4